<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02630160</url>
  </required_header>
  <id_info>
    <org_study_id>2013/5138/I</org_study_id>
    <nct_id>NCT02630160</nct_id>
  </id_info>
  <brief_title>The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement</brief_title>
  <acronym>ILIACPCPTHR</acronym>
  <official_title>The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized double-blind clinical trial was performed. There were 4 groups according to
      catheter placement and infusion constituents: 1) Intraarticular catheter + anesthetics; 2)
      Intraarticular catheter +placebo; 3) Subfascial catheter + anesthetics; 4) Subfascial
      catheter + placebo. The anesthetics infusion contained bupivacaine (bolus + continuous
      perfusion up to 36 hours). The placebo solution consisted in physiological serum (bolus +
      continuous perfusion up to 36 hours). Randomization was performed in the hospital pharmacy
      and the surgeon kept out the surgical field when the resident placed the catheter. The same
      conventional analgesic schedule was prescribed to all patients: PCA (patient controlled
      analgesia) + paracetamol 1g/6h + dexketoprofen 50mg/12h. The pain was evaluated by means of
      PCA (patient controlled analgesia) shots and the VAS (visual analog scale). Side effects,
      time to start rehabilitation and time to discharge were also analyzed. A statistical analysis
      was performed to compare all this variables between the 4 groups (SPSS 18.0).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain measured with a visual analog scale</measure>
    <time_frame>36 hours</time_frame>
    <description>Visual analog pain scale score every eight hours for 36 hours postoperatively</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Musculoskeletal Pain</condition>
  <condition>Hip Injuries</condition>
  <arm_group>
    <arm_group_label>Intraarticular Catheter with anesthesic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraarticular infusion with Bupivacaine Hydrochloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraarticular Physiological Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Infusion of Physiological Saline [Flebobag Salina Fisiologica Grifols 0.9%] Sterile Solution by intraarticular catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perifascial Catheter with anesthesic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Perifascial infusion with Bupivacaine Hydrochloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Perifascial Physiological Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Infusion of Physiological Saline [Flebobag Salina Fisiologica Grifols 0.9%] Sterile Solution by Perifascial catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine hydrochloride</intervention_name>
    <description>Intraarticular infusion with bupivacaine</description>
    <arm_group_label>Intraarticular Catheter with anesthesic</arm_group_label>
    <arm_group_label>Perifascial Catheter with anesthesic</arm_group_label>
    <other_name>Bupivacaine / epinephrine, Vivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiological Saline</intervention_name>
    <description>Intraarticular infusion physiological serum</description>
    <arm_group_label>Intraarticular Physiological Saline</arm_group_label>
    <arm_group_label>Perifascial Physiological Saline</arm_group_label>
    <other_name>Flebobag Salina Fisiologica Grifols 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary total Hip Replacement

        Exclusion Criteria:

          -  Allergic to Bupivacaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Pérez Prieto</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marta Cuenca Llavall</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Marques Lopez</last_name>
    <role>Study Director</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alfonso Leon Garcia</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francisco Javier Santiveri Papiol</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital del Mar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>December 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2015</study_first_posted>
  <last_update_submitted>October 10, 2016</last_update_submitted>
  <last_update_submitted_qc>October 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parc de Salut Mar</investigator_affiliation>
    <investigator_full_name>Daniel Pérez Prieto</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Pain</mesh_term>
    <mesh_term>Hip Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

